Vital Neuro, Inc.

Stress is a massive problem in the workplace, costing U.S. businesses $30 billion yearly in loss within workdays alone. People see their jobs as creating stress, and employers need to do more to help. Current solutions are expensive, time-consuming, ineffective, and not measurable. Certain industries are so stress led that the work environment has catapulted turnover to historical record levels. Further, daily distractions hinder career related focus and success. This lack of sustained focus and elevated stress stifles productivity, career advancement, and lowers profitability. Vital Neuro’s innovative science-based platform offers a solution to these issues through stress reduction as a service. A Mobile SaaS for enterprise customers where employers provide their team members with enjoyable, neuroscience-based stress reduction sessions built on real time monitoring of personal biosignals. The results...improved job satisfaction, increased productivity, lowered employee turnover, and increased EBITDA. This advanced brain training paradigm is an innovative blend of neurofeedback, scientifically designed sound and music, and other neuro modulation techniques, that are based on brain plasticity; the brain’s ability to change. Vital Neuro’s groundbreaking solution is delivered through stylish, wireless, high fidelity headphones and an app that ties to Vital’s Leonardo smart cloud platform.Based on 50+ years of combined research, Vital Neuro’s technology delivers a customized solution by offering science-based features. By measuring the real time biosignals of the brain, a calming audio and/or audio & video experience is delivered in response to reduce the subscriber’s stress levels.Vital Neuro’s solution takes real time physiological data to assess and assign the precise audio/video content needed to deliver a quantifiable stress management solution to a growing subscriber base. While focusing our sales and distribution efforts on enterprises with a very large number of employees, Vital Neuro will reduce workplace stress by bringing employees back to a state of equilibrium, thus achieving balance within the workplace.

Cloud service delivery using clinically practiced and tested scientific stress reduction programs
Secure cloud platform on Amazon Web Services (“AWS”) for capturing and acting on electroencephalogram (“EEG”) and other biometric data to reduce costly and harmful stress in enterprises
No U.S. Food and Drug Administration (“FDA”) regulatory approvals needed for product development, testing, and sale of our initial products
Actionable, commercial, annuity model
Our current projections suggest we will be able to achieve a cash flow positive status in an expedited manner

• 20% Technology development
• 20% Enterprise sale growth
• 20% Product perfection
• 20% Acquisitions complimentary business
• 10% Token community incentives
• 2.5% Dept repayment
• 2.5% General corporate
• 2.5% Market promotion
• 2.5% Professional

Q Saeed
Founder & Chief Executive Officer
25+ years of proven executive leadership and extensive start up experience | Pioneered exclusive development & launch of first converged cellular Blackberry to the enterprise | Co-founded Open Range Communications closing $400M of green field funding

Kamran Fallahpour, PHD
Founder & Chief Science Officer
Licensed Clinical Psychologist and Neuroscientist with 25+ years of clinical research, and product experience in neurophysiology, biomarker, brain computer interface, and sensor technology | Founder and Director, The Brain Resource Center | Clinical Instructor at Icahn School of Medicine at Mount Sinai Hospital

Alex Doman
Founder & Chief Product Officer
Founder & CEO Advanced Brain Technologies | Co-Founder Sleep Genius | 3rd generation pioneer in the field of human brain development | 25 years of experience bringing products & technologies to market | TEDx Speaker and named Top 50 Human Behavior Expert to watch

Bruce J. Clay
Founder & EVP of Finance and Corporate Development
Past Executive Vice President at First American Title Insurance Company of NY | Served on FATCONY Board of Directors beginning in 1992 and as Chair of the Finance Committee since 2001 | Bruce has closed tens of billions of dollars of transactions with capital market firms, pension funds and insurance companies

The Company is offering rights to an aggregate of $45,000,000 Neuros Tokens[1] pursuant to SAFEs in three offerings 

• Neuros Token may, at its sole discretion, raise up to $50,000,000 with this offering upon market demand dictates.
• Represents the total proceeds before distribution fees and offering expenses, (“see plan of distributions” for more information) Neuros Token may engage registered marketing agents or finder’s in connection with the distribution of this offering and pay such agents’ commission up to 8% of the aggregate purchase price for the SAFEs placed by such agents.
• Represents the Neuros Tokens underlying SAFE pursuant to Rule 506(c) of Regulation D of the Securities Act.
• Neuros Token, Inc. reserves the right, at its sole discretion, to increase the aggregate number of Neuros Tokens issuable pursuant to the SAFEs sold in the offerings, based on market demand, not to exceed a total market raise of $50,000,000.  Tokens not sold will be burned, and only 1,588,500 will be retained in the Company treasury.
• Proceeds to Company will be variable on market demand, not to exceed $50,000,000 before fees and expenses.